Results: 31

Cáncer de próstata: análisis de tasa de mortalidad, periodo 2017-2021 en Chile

Rev. ANACEM (Impresa); 16 (2), 2022
Introducción: El cáncer de próstata (CP) es una neoplasia dependiente de hormonas de la próstata. Presenta una mortalidad mundial en descenso, disminuyendo de 39 a 19 por cada 100.000 personas; En Chile no existen datos recientes. Objetivos: Describir la tasa de mortalidad (TM) por cáncer de próst...

Prostate Cancer Survival and Mortality according to a 13-year retrospective cohort study in Brazil: Competing-Risk Analysis

ABSTRACT: Objective: To analyze cancer-specific mortality (CSM) and other-cause mortality (OCM) among patients with prostate cancer that initiated treatment in the Brazilian Unified Health System (SUS), between 2002 and 2010, in Brazil. Methods: Retrospective observational study that used the Nationa...

Lugar de residencia y grado de marginación como factores pronóstico de supervivencia al cáncer de próstata en Veracruz, México

Resumen Objetivos: Determinar si el lugar de residencia y el grado de marginación se encuentran asociados a la supervivencia al cáncer de próstata. Materiales y métodos: Se incluyeron a todos los pacientes diagnosticados con cáncer de próstata (CP) en el periodo 2013-2017 en un hospital de terc...

Morbimortalidade de câncer de próstata

Objetivo: Analisar o perfil epidemiológico da mortalidade por câncer da próstata, identificando fatores de risco para a pato- gênese. Métodos: Estudo retrospectivo, populacional. Os dados analisados foram coletados do Sistema de Informação sobre Mor- talidade e Informações de Saúde. O desfech...

Trends in prostate cancer mortality in the state of São Paulo, 2000 to 2015

ABSTRACT OBJECTIVE To estimate the magnitude and identify patterns of change in prostate cancer mortality in the state of São Paulo and in the 17 regional health care networks, according to age groups from 50 years onwards, in the period between 2000 to 2015. METHODS Age-adjusted mortality rates (pe...

High D-dimer levels are associated with prostate cancer

RESUMO OBJETIVO O câncer de próstata é uma das neoplasias mais comuns em homens. Os principais fatores de risco para a ativação da coagulação e trombose são malignidade e idade mais avançada. O risco de trombose pode estar associado ao aumento do nível dos marcadores de coagulação, tais com...

Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: Is there any clinical difference?

Int. braz. j. urol; 45 (6), 2019
ABSTRACT Purpose: To compare the treatment outcomes of a cohort of prostate cancer patients treated with conventional schedule using IMRT or 3DRT technique. Materials and Methods: Between 2010-2017, 485 men with localized prostate cancer were treated with conventional radiotherapy schedule with a total...

Herramientas de ayuda para la toma de decisiones compartidas en tamizaje de cáncer de próstata
Decision aids for shared decision making in prostate cancer screening choice

Mortalidade em homens com câncer de próstata e sua associação com variáveis sociodemográficas e clínicas

Objective: The study’s purpose has been to evaluate the association of socio-demographic and clinical variables with the general and specific mortality from prostate cancer. Methods: This is a retrospective study that was carried out through the analyses of medical records from 1,290 men diagnosed with...

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort

Int. braz. j. urol; 45 (2), 2019
ABSTRACT Objectives: Brachytherapy (BT) with iodine-125 seeds placement is a consolidated treatment for prostate cancer. The objective of this study was to assess the clinical outcomes in patients with prostate cancer who underwent low-dose-rate (LDR) -BT alone in a single Brazilian institution. Materi...